NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
00703-4014-11 | 00703-4014 | Leuprolide Acetate | Leuprolide Acetate | Hormonal Therapy | GnRH Agonist | Subcutaneous | Nov 6, 2000 | Mar 31, 2011 | No Longer Used | ||
83634-0454-61 | 83634-0454 | Leuprolide acetate | Leuprolide Acetate | 5.0 mg/mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Mar 15, 2025 | In Use | ||
00074-3473-03 | 00074-3473 | Leuprolide Acetate | Lupron Depot | Hormonal Therapy | GnRH Agonist | Dec 23, 1995 | In Use | ||||
72664-0611-28 | 72664-0611 | Leuprolide Acetate | Leuprolide Acetate | Hormonal Therapy | GnRH Agonist | Oct 25, 2020 | In Use | ||||
16714-0572-01 | 16714-0572 | Leuprolide acetate | Leuprolide acetate | 5.0 mg/ml | Hormonal Therapy | GnRH Agonist | Subcutaneous | Aug 1, 2022 | Sep 30, 2024 | No Longer Used | |
50090-3466-00 | 50090-3466 | Goserelin acetate | ZOLADEX | 3.6 mg/1 | Hormonal Therapy | GnRH Agonist | Subcutaneous | May 30, 2018 | In Use | ||
00185-7400-14 | 00185-7400 | Leuprolide Acetate | Leuprolide Acetate | 1.0 mg/.2mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Jan 6, 2011 | In Use | ||
00024-0610-30 | 00024-0610 | Leuprolide Acetate | Eligard | Hormonal Therapy | GnRH Agonist | Subcutaneous | Jan 23, 2002 | May 31, 2016 | No Longer Used | ||
00023-5906-23 | 00023-5906 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Mar 11, 2010 | In Use | ||||
52544-0156-02 | 52544-0156 | Triptorelin Pamoate | Trelstar | 22.5 mg/2mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Mar 11, 2010 | Oct 31, 2018 | No Longer Used | |
62935-0222-05 | 62935-0222 | Leuprolide Acetate | Eligard | Hormonal Therapy | GnRH Agonist | Subcutaneous | Aug 26, 2002 | Apr 26, 2019 | In Use | ||
52544-0092-76 | 52544-0092 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Mar 11, 2010 | Oct 31, 2018 | No Longer Used | |||
00023-5904-12 | 00023-5904 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Jun 29, 2001 | In Use | ||||
00023-5902-04 | 00023-5902 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Jun 15, 2000 | In Use | ||||
62935-0461-50 | 62935-0461 | Leuprolide acetate | Eligard | 45.0 mg/.375mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Mar 6, 2023 | In Use | ||
62935-0223-05 | 62935-0223 | Leuprolide Acetate | Eligard | Hormonal Therapy | GnRH Agonist | Subcutaneous | Aug 26, 2002 | In Use | |||
00074-3346-03 | 00074-3346 | Leuprolide Acetate | Lupron Depot | Hormonal Therapy | GnRH Agonist | Dec 23, 1995 | In Use | ||||
83831-0134-01 | 83831-0134 | Leuprolide acetate | LUTRATE DEPOT | 22.5 mg/2ml | Hormonal Therapy | GnRH Agonist | Intramuscular | Mar 26, 2025 | In Use | ||
55150-0478-01 | 55150-0478 | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Hormonal Therapy | GnRH Agonist | Jun 6, 2022 | In Use | ||||
72843-0591-99 | 72843-0591 | Leuprolide acetate | Leuprolide acetate | 5.0 mg/ml | Hormonal Therapy | GnRH Agonist | Subcutaneous | Oct 25, 2024 | In Use | ||
49884-0368-26 | 49884-0368 | Leuprolide Acetate | Leuprolide Acetate | Hormonal Therapy | GnRH Agonist | Nov 29, 2001 | Mar 31, 2010 | No Longer Used | |||
52544-0153-02 | 52544-0153 | Triptorelin Pamoate | Trelstar | 3.75 mg/2mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Jun 15, 2000 | Oct 31, 2018 | No Longer Used | |
00185-7400-85 | 00185-7400 | Leuprolide Acetate | Leuprolide Acetate | 1.0 mg/.2mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Aug 4, 1998 | In Use | ||
69097-0909-50 | 69097-0909 | Leuprolide acetate | LEUPROLIDE ACETATE DEPOT | Hormonal Therapy | GnRH Agonist | Jul 15, 2022 | In Use | ||||
52544-0154-02 | 52544-0154 | Triptorelin Pamoate | Trelstar | 11.25 mg/2mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Jun 29, 2001 | Oct 31, 2018 | No Longer Used |
Found 11765 results — Export these results